Mebias is a Pennsylvania-based biopharmaceutical company that researches and develops GPCR drugs for the treatment of pain and neuroinflammation.
Business Model:
Revenue: $5M
Employees: 2-10
Address: 3675 Market Street
City: Philadelphia
State: PA
Zip: 19104
Country: US
Mebias is a Pennsylvania-based biopharmaceutical company that researches and develops GPCR drugs for the treatment of pain and neuroinflammation.
Contact Phone:
+12672180854
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2019 | Equity | $3.5M |
Sprout BioVentures Viva Biotech |
2/2017 | Venture Round | 1 | - |
BioAdvance BioAdvance |
9/2022 | Equity | $630.7k | 9/2016 | Venture Round | 1 | - |
BioAdvance BioAdvance |
10/2020 | Grant | $7.1M |
National Institute on Drug Abuse |
9/2018 | Grant | $2.6M |
National Institute of Drug Abuse |
9/2022 | Venture Round | $630.7k | 3/2016 | Seed Round | 1 | - |
BioAdvance BioAdvance |
10/2019 | Venture Round | 2 | $3.5M |
Sprout BioVentures Sprout BioVentures Viva Biotech |
2/2017 | Venture Round | 1 | - |
BioAdvance BioAdvance |
9/2016 | Venture Round | 1 | - |
BioAdvance BioAdvance |
3/2016 | Seed Round | 1 | - |
BioAdvance BioAdvance |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|